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839FO-6 The Impact of Sirolimus-Eluting Stsnts in Diabetics: 
Results From the SIRIUS Trial 
lesion is waived, Pts have a 9 fold increased nsk for major adverse cardiac events during 
the following year despite a FFR 2 0.75. However, whether FFR based therapy stratifica- 
tion in these patients requires other cut off values is subject to further investigations. 
Martin B. Leon, David R. Holmes, Charles Simonton, Jeffrey W. Moses, Charles 
Q’Shaughnessy, Ronald P. Caputo, Shing C. Wang, Maurice Buchbinder, Greg 
Chapman, Richard E. Kuntz, Cardiovascular Research Foundation, New Y&k, NY 
1149-188 The Importance of Intravascular Ultrasound in 
Percutaneous Coronary Intervention for Small Coronary 
Arteries 
Background: Diabetics after coronary stent implantation manifest more frequent major 
adverse cardiac events (MACE) and increased restenosis @es). However, the effects of 
sirolimus-eluting stents @ES) in diabetics is poorly understood. 
Methods: In the randomized double-blind SIRIUS trial (1058 patients), which compared 
SES vs. control bare stents (CS). 26.4% of patients were diabetic. Within the diabetic 
subgroup (279 patients), lesion length was 14.5mm and reference vessel diameter was 
2.75mm. 
Kunihiro Matsushita, Haruo Hirayama, Mamoru Nanasato, Nagoya Daini Red Cross 
Hospital Cardiovascular Center, Nagoya, Japan 
Results: Follow-up angiography (8 6 months) and MACE (up to 9 months) were com- 
pared in the SES vs. CS diabetic subgroups (see table). Similar to the overall SIRIUS 
cohort, diabetics had greater Res and target lesion revascularization (TLR) in the small 
and medium size vessels (tercile analysis) and a disproportionate contribution to Res 
withm the proximal peri-stem region (46% in SES vs. 27% in CS). Among the diabetics, 
patients on insulin (n=62), demonstrated reduced angiographic and clinical benefit after 
SES therapy. 
Conclusions: Analysis of the diabetic SIRIUS patients indicates: (1) preserved SES rel- 
ative treatment effect on Res and TLR, despite higher absolute values; (2) clustering of 
Res and TLR events in the smaller vessels, due to relatively higher proximal peri-stent 
late loss; (3) reduced SES efficacy in diabetics on insulin therapy. Further improvement 
in SES results in diabetics may require increased stent coverage of peri-stent regions 
(esp. proximal). 
Follow-up parameter SES (n=l31) CS (n=l46) pvalue 
Late loss (mm): in-stent 0.29 1.20 <O.OOl 
Late loss (mm): in-lesion 0.40 1.00 <O.OOl 
Res (%): in-stem 6.3 46.5 <0.001 
Res (%): in-lesion 17.6 50.5 <O.OOl 
TLR (%) 7.2 22.9 <O.OOl 
MACE (%) 9.2 25.0 <0.001 
Background: Angioplasty of lesions in small coronary arteries remains a significant prob- 
lem because of the increased risk of restenosis. While we usually use quantitative coro- 
nary angiography (QCA) to define small coronary arteries, previous studies reported that 
QCA for small coronary arteries was not accurate. We studied the difference of resteno- 
sis rate between truly small coronary arteries (groupl) and falsely small coronary arteries 
(group2) divided by intravascuar ultrasound(lVUS). 
Methods: We studied 102 lesions whose reference diameter (RD) were less than 2.6 mm 
by QCA. These lesions were divided into 2 subgroups according to lumen diameter (LD) 
by IVUS (group 1: LD 2.5mm). The difference of restenosis rate was evaluated after 6 
months follow-up. 
Results: Baseline clinical and angiographlc characteristics were similar in the two groups. 
According to IVUS, 43 cases (42.2%) were defined as falsely small coronary arteries (LD 
> 2.5mm). RD by QCA are similar in two groups(2.31+0.04 vs 2.42kO.04, p=ns, respec- 
tnely). The rate of stenting was not significantly different (66.4% YS 95.3%, p=ns, respec- 
twely). Post-procedural lumen diameter was significantly larger in falsely small coronary 
arteries group (2.34+0.07 vs 2.71+0.09, p<O.OOl). The angiographic restenosis rate was 
44.1% in truly small coronary arteries group, and 20.9% in falsely small coronary arteries 
group (P<O.O5). 
Conclusion: Some small coronary arteries defined by QCA have LD more than 2.5mm by 
IVUS. In these lesions, the restenosis rate was almost similar with lesions more than 3.0 
mm. To discuss proper procedures for small coronary arteries, we should define small 
coronary arteries by IVUS. 
1149-189 Chronic Kidney Disease: The Silent Killer After 
Coronary Angioplasty 
Gurudutt B. Kulkarni, John House, John A. Spertus, Peter A. McCullough, University of 
Missouri-Kansas City School of Medicine, Truman Medical Center, Kansas City, MO, St. 
Luke’s Hospital, Mid America Heart Institute, Kansas City, MO 
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1149-187 Deferring of Patients With Rsstsnotic Coronary Lesions 
Based on the Concept of Fractional Flow Reserve 
Measurement 
Background: There is evidence that chronic kidney disease (CKD) is associated with 
increased mortality in patients undergoing PCI. The impact of CKD on quality of life 
(QOL) in PCI patients is unknown. 
Methods: We analyzed a prospective PCI regisby where CKD was categorized by crea- 
tinine clearance (CrCl) as mild (61-90 mllmin), moderate (31-60 mllmin) and severe (15- 
30 mllmin) and compared to those with normal CrCI. Patients with CrCl < 15 m!lmin or on 
hemodialysis were excluded. The Seattle Angina Questionnaire (SAQ) was administered 
at the time of the procedure and at 1 year. Mortality data was obtained from the National 
Death Index. Univariate and multivariate regression analyses were used. 
Results: 1,324 patients with CKD and 232 patients with normal renal function were stud- 
ied.There was more physical limitation in those with moderate and severe CKD but no 
difference in angina frequency or QOL at baseline. One-year mortality was 20.3, 5.9, 3.3 
and 1.7% for the severe, moderate, mild CKD, and normal renal function patients respec- 
tively (p < 0.001). By logistic regression analysis, severe CKD was the strongest inde- 
pendent predictor of death (Table). 
Johannes Rieber, lsabelle Erhard, Tobias Segmiller, Andreas Koenig, Thomas M. 
Schiele, Hagen Gross, Silke Ebel, Karl Theisen, Volker Klauss, Medizinische Klmik, 
University of Munich, Munich, Germany 
lntracoronary pressure measurement is a promising mettiod to invasively quantify the 
hemodynamic relevance of intermediate coronary lesions. Patients with coronary single 
vessel-disease and a Fractional Flow Reserve (FFR) > 0.75 across a de-nova coronary 
. lesion have a very low incidence for developing a maGr adverse cardiac event (MACE) 
during a follow-up of 24 months and should therefor not receive an intervention. How- 
ever, it is still unclear if this is also true in restenotic coronary lesions. The aim of the 
present study was to Investigate whether deferring of patients based on the measure- 
ment of FFR is also a safe option in restenotic lesions. 
Methods: 59 consecutive patients (Pt) (mean age S%lO ys) with stenoses of angio- 
graphically questionable relevance and a FFR > 0.75 were Included into the study. Based 
on the FFR measurement PTCA was avoided in all 47 patients with de-nova lesions (DL) 
. and 12 patients with restenotic lesions (RL). Patients were closely monitored on an out- 
patient basis. Primary endpoint was the occurance of major adverse cardiac events 
(rePTCA, CABG, myocardial infarction. death). Secondary endpoints were the time to 
revascularization procedures if performed during the follow-up as well as the change in 
angina status. 
Results: Mean follow-up was 492 * 252 days. The coronary risk profile as well as patient 
characteristics were similar in both groups. During first year 4 major adverse cardiac 
events occured ([DL] PTCA n=l; [RL] PTCA n=3). The risk for the development of major 
adverse clinical events during the first year was 2% in the DL-group and 16% in the RL- 
group (OR 9,0 p-=0,05). Time to revascularization procedures was 175 days (DL) and 
202265 days (RL). However, no significant change ln angina status was observed. 
Conclusion : FFR can accurately Identify patients at low risk for the development of 
major adverse cardiac events in de-nova lesions. If an intended PTCA in a restenotic 
OR for Death (95% Cl) Change QOL 
*P<o.ool P=NS 
Severe CKD 8.6 (2.2-33.5) * 33+/-28 
Moderate CKD 3.0 (0.9-10) 31+/-24 
Mild CKD 2.2 (0.7-7.7) 30+/-26 
At follow-up, there was no difference in the angina frequency, physical limitations or QOL 
among those with and without CKD. 
Conclusions: CKD is the most powerful independent predictor of mortality in PCI 
patients. These data suggest CKD signals a unique state of vascular pathobiology that is 
silent in terms of QOL measures, but lethal in terms of ultimate outcome. 
1149-190 Deceptive Ostial Coronary Lesions: Lack of 
Relationship Between Imaging and Physiology 
Ali Ziaee Sanjeev Puri, Steven C. Herrmann, Saad Bitar, Frank Bleyer, Souheil -I 
Khoukaz, Morton J. Kern, St. Louis University, St. Louis, MO 
Background: Estimation of ostial lesion severity by angiography has significant limita- 
tions due to angulation, branch overlap and artifact. To compare angiography and physi- 
ology, ostial diameter stenosis was compared to fractional flow resewe (FFR) in 31 
consecutive patients with 38 lesions 2 50% diameter narrowing. 
Methods: FFR was obtained with a 0.014” pressure guidewire and intracoronary ade- 
nosine (30-50 mcg). Two independent obsewers determined angiographic severity. 
Patients were divided into two groups by the degree of stenosis (270% stenosis and 50- 
70% stenosis). 
Results: The ostial lesions assessed were left main (n=5), anterior descending (n=6), 
diagonal (n=3), circumflex (n=7). marginal (n=3), right (n=6), posterior descending (n=3), 
and internal mammary (n=2). For _z 70% stenosis, FFR was 0.65 _+ .09; for ostial lesions 
between 50-70%, FFR was 0.91 + 0.03. In 18 ostial lesions with ) 70% stenosis, FFR 
was 20.75 in 15 and FFR co.75 in 3. All 20 ostial lesions with angiographic stenosis 
between 50.70% had FFR 2 0.75 (Yate’s p=O.O006, see table) 
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Conclusion: A significant “umber of &al lesions with angiographic stenosis> 70% an? 
associated with a physiologic nonischemic threshold (i.e. FFR -> 0.75). Ostial lesions 
without evidence of ischemia should undergo physiologic testing before interventions. 
Ostial Lesions: Angiography vs FFR 







1149-l 91 Cutting Balloon Atherotomy Is Associated With 
Decreased Stent Utilization 
Jeffrey A. Goldstein. Jason H. Rogers, Ivan P. Casserly. John M. Lasala, Howard I. Kurz. 
Jasvindar Singh, Richard G. Bach, Morton R. Rinder, Megumi Taniuchi, Washington 
University School of Medicine, Saint Louis, MO 
Background: Cutting balloon atherotomy (CBA) achieves luminal gain by creating con- 
trolled fissuring of coronary plaques. In a retrospective comparison of CBA to other tech- 
niques for treatment of non-intrastent lesions at Barnes-Jewish Hospital, CBA was 
associated with decreased need for stent implantation (50% vs. 66.4%), greater angio- 
graphic and clinical success (99.6% vs. 97.9% and 99.3% vs. 95.9%), and no difference 
in 1 and 9 month target vessel revascularization (TVR) (1.6% vs. 0.9%, and 15% vs. 
12%, respectively). The Cuffing Balloon as Sole Revascularization Trial compares CBA 
with conventional balloon angioplasty (POBA) as the primary treatment for non-intrastent 
lesions. Methods: Patients undergoing percutaneous revascularization for native coro- 
nary artery lesions are randomized to CBA or POBA as primary treatment. Provisional 
stenting is indicated for z-35% residual stenosis, grade B or greater dissection, or throm- 
bus. The primary endpoint is stent implantation for sub-optimal results. Secondary end- 
points include in-hospital MACE and 1 and 9 month TLR. Results: Twenty-two patients 
have been randomized to the CBA group and 17 patients to the POBA group. Clinical 
characteristics. vessels treated, and lesion types are similar between the two groups. To 
date, CBA has achieved greater angiographic success as primary therapy (67.0% vs. 
57.7%; p=O.O2), with fewer dissections (22.2% vs. 45.5%, p=NS) compared to conven- 
tional angioplasty. CBA is associated a decreased need for stent implantation (27.6% vs. 
61.6%; p<O.OOl). Despite lower stent utilization in the CBA group, there is no difference 
in final stenosis (14.5% vs. 14.0%). 
Conclusions: As primary therapy, CBA appears to achieve greater angiographic suc- 
cess with decreased need for stent implantation compared to POBA. Updated enrollment 
with cost analysis, 1 month and 9 month outcomes will be presented. A model for com- 
paring cost-benefit of CBA compared to implantation of drug-coated stents will be dis- 
cussed. 
1149-192 Diabetes Does Not Add to the Increased Six-Month 
Mortality Associated With Increase in CK-MB After 
Percutaneous Coronary intervention 
Sanieev Puri, Bernard R. Chaitman, Jeffrey A. Gavard, Shunta Sakai, Karen Stocke. Leif 
Erhardt. Eric Chi. Andreas Jessel, Richard Gallo, Pierre Theroux, for the GUARDIAN 
Investigators, St. Louis University School of Medicine, St. Louis, MO 
Background: Increased CK-MB release after percutaneous coronary intervention (PCI) 
is associated with increased mortality. It is not known if the prognosis of diabetic (D) pts 
with increased CK-MB levels after PCI is different than nondiabetic (ND) pts. 
Methods: The GUARDIAN trial contained 2,173 PCI pts who had prospectively acquired 
baseline clinical and post-PC1 CK-MB and ECG data. The incidence and B-month mortal- 
ity associated with different levels of CK-MB were compared between 516 D pts and 
1,657 ND pts. 
Results: The incidence of peak CK-MB elevation in D pts was not greater than in ND pts 
(table). The D subgroup was older (median age 64.0 vs. 62.0, p.zO.05); had more females 
(33.3% vs. 22.7%, p<O.OOl) and fewer whites (66.6% vs. 94.5%, p<O.OOl); was more 
obese (media” body mass index 29.0 vs. 27.3. p<O.OOl): had a higher systolic blood 
pressure (median 134.0 vs. 130.0, p<O.OOl); and was more likely to have a history of 
heart failure (15.7% vs. 7.0%. pcO.OOl), cerebrovascular disease (11.4% vs. 6.0%, 
p<O.O5), and peripheral vascular disease (16.0% vs. 9.6%. pcO.001) than the ND sub- 
group. The 6-month mortality rates in D were usually slightly greater than in ND at any 
particular peak CK-MB ratio cutoff, but “one were statistically significant (table). 
Conclusion: The incidence and magnitude of CK-MB leaks following PCI is no greater in 
D than in ND. D have a more adverse risk profile than ND, but for any given level of peak 
CK-MB release post-PCI, diabetes does not significantly elevate 6-month mortality risk. 
Incidence of Peak CK-MB Ratio in PCI 6-Month Mortality in PCI Patients by Peak 
Patients (%) CK-MB Ratio Cutoffs (%) 
<l 51<3 z33<5 s >I0 <1 ULN >3ULN >5ULN >lOULN 
UL ULN ULN <lO ULN 
N ULN 
Diabeti 67. 21.3 5.0 2.9 2.9 3.1 3.6 6.7 6.7 
c 6 
Non- 63. 23.5 5.7 3.7 3.1 1.4 3.6 5.3 5.9 
diabeti 9 
c 
p=o.57 p=o.c6 p=1.00 p=1.00 p=l.OO 
1149-193 Long-Term Outcome of Patients With Prior 
Percutaneous Revascularization Undergoing Repeat 
Coronary intervention 
Heidar Arjomand, David R. Holmes, James T. Wilierso”, Bassam Roukoz. Satish 
Surabhi, Andrev Espinoza. Daniel McCormick, Zoltan G. Turi, Sheldon Goldberg, Drexel 
University College of Medicine, Philadelphia, PA, Mayo Clinic, Rochester, MN 
Background: Patients (pts) with a history of prior percutaneous coronary revasculariza- 
tion (PCR) are often excluded from clinical trials. As a result, there is limited data on the 
outcome of these pts undergoing repeat coronary intervention. 
Method: Of 11,262 pts undergoing percutaneous coronary intervention (PCI) in the Pre- 
vention of Restenosis with Tranilast and its Outcomes (PRESTO) trial, 3,495 pts had his- 
tory of prior PCR, 2l3 of whom had prior stent placement. We compared the outcome of 
these pts with 7,767 pts with de “ova lesions. 
Results: Mean age was 60 yrs in both groups. Pts with prior PCR were more likely to 
have DM (26% vs 22%, P < O.OOl), HTN (70% vs 57%, p < O.OOl), hypercholesterolemia 
(66% vs 47%. p < O.OOl), prior Ml (56% vs 31%, p < O.OOl), and prior CABG (23% vs 
9%, p < O.OOl), and less likely to have new-onset angina (21% vs 26%, p < O.OOl), signif- 
icant EKG changes (6% vs ll%, p < O.OOl), or be current smokers (17% vs 25%, p < 
0.001). Angiographic features in pts with and without history of PCR. respectively, 
included: ostial lesions (10% vs 6%. p < O.OOl), total occlusion (6% vs IO%, p < 0.001). 
ejection fraction (60.9% vs 56.6%, p < O.Ol), and LAD location (31% vs 41%, p < 0.001). 
Ilb/llla was used in 39% and 35% respectively (p < 0.001). In-hospital rates of cardiac 
events were low and similar. Kaplan-M&r estimates of events at 9 months an? shown 
(table). 
Conclusions: Despite similar in-hospital outcomes, patients with a history of prior PCR 
have a significantly lower event-free suwival at B-month follow-up. 
Kaplan-M&r Estimates of Cardiac Events at 9-month Follow-up 
Variable Prior PCR No Prior PCR 
Estimate (95% Cl) Estimate (95% Cl) 
P value 
Death 1.7(1.1-2.2) 1.2 (0.9-l .6) 0.059 
Ml 2.0 (1.4-2.5) 1.3 (1.0-l .6) 0.016 
CABG 7.6 (6.6-6.7) 3.2 (2.7-3.7) < 0.001 
Death or Ml 3.4 (2.6-4.1) 2.5 (2.0-2.9) 0.012 
Death, MI. or CABG 10.1 (6.9-11.4) 5.4 (4.7-6.0) < 0.001 
1149-194 Rupture of the External Elastic Lamina Increases 
Plaque Neovascularization After Coronary Angioplasty 
in the Swine Model 
Dario Echeverri German Santamaria, Valentin Fuster, William N. O’Connor, Pedro R. 
Moreno, University of Kentucky, Lexington, KY, Fundacion Cardio-lnfantil, Bogota, 
Colombia 
Background: While plaque “eovascularization (NV) is associated with neointimal prolif- 
eration alter vessel wall injury, rupture of the external elastic lamina (EEL) may increase 
this angiogenic response. We tested the hypothesis that plaque NV is increased in coro- 
nary lesions with EEL rupture after balloon angioplasty in the swine model. 
Materials and Methods: Thirty-nine histological sections from ballooned coronary artery 
angioplasty segments were studied after 6 weeks of barotrauma. Rupture of EEL was 
defined as extensive tissue interruption along the media-adventitia interface on 40x light 
microscopy. Neovessels were defined as tubuloluminal anti-vWF positive capillaries rec- 
ognized in immunostained sections by light microscopy. Morphometric measurements 
wsre performed by computerized planimetry. 
Results: Plaque NV was increased in lesions with rupture of EEL (Table). Neointimal 
area was increased and lumen area was decreased in lesions with rupture of EEL 
(Table). EEL area was similar in both groups. Multiple regression analysis identified rup- 
ture of EEL as a” independent predictor for plaque NV (RR=l9.6; 95% Cl=2.4-37). 
Conclusion: Neovascularization is increased in coronary plaques with rupture of the 
external elastic lamina following vessel wall injury. This angiogenic response is associ- 
ated with increased neointima formation and reduced lumen ares. Thus, novel anti- 
angiogenic therapies may offer a” alternative option for the prevention of restenosis. 
